Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI) |
Acute Kidney Injury Due to Sepsis | Phase2 | Argentina Australia Austria Belgium Brazil Canada China France Germany Hungary India Italy Japan South Africa Spain Thailand United Kingdom United States View all |
NCT05996835 |
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis |
Scleroderma, Diffuse | Phase2 | Australia Austria Czechia Denmark France Germany Hungary Israel Italy Japan Netherlands Singapore South Korea Spain Switzerland Taiwan United States View all |
NCT06655896 |
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG. |
Generalized Myasthenia Gravis | Phase3 | China Denmark Greece Israel Italy Japan Poland Portugal Spain United Kingdom United States View all |
NCT06517758 |
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V |
Lupus Nephritis | Phase2 | Argentina Brazil China Colombia France Germany Hong Kong Hungary India Israel Malaysia Mexico Philippines Portugal Puerto Rico Singapore Spain Turkey (Türkiye) United Kingdom United States View all |
NCT05268289 |
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors |
Solid Tumor | Phase1, Phase2 | Australia Canada France Italy United States View all |
NCT04939610 |
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers | Phase1 | Belgium China France Germany Israel Italy Japan Norway Singapore South Korea Spain Sweden Taiwan United Kingdom United States View all |
NCT05838768 |
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). |
Systemic Lupus Erythematosus | Phase3 | Argentina Australia Brazil Bulgaria Canada Chile China Colombia Czechia France Germany Guatemala Hungary India Israel Italy Japan Malaysia Mexico Poland Portugal Romania South Africa South Korea Spain Taiwan Thailand United States View all |
NCT06133972 |
Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France |
Chronic Myeloid Leukemia | France | NCT06092879 | |
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer |
Breast Cancer | Phase1 | China France Germany Poland Portugal Spain United States View all |
NCT05870579 |
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS |
Atypical Hemolytic Uremic Syndrome | Phase3 | Brazil China Czechia India View all |
NCT05795140 |